关键词: Atrial fibrillation Left atrial appendage flow velocity Left atrial thrombus Oral anticoagulant Transesophageal echocardiography

Mesh : Humans Atrial Fibrillation / physiopathology complications Male Female Atrial Appendage / diagnostic imaging physiopathology Aged Thrombosis / physiopathology diagnostic imaging complications Echocardiography, Transesophageal Middle Aged Blood Flow Velocity Anticoagulants / therapeutic use Risk Factors Treatment Outcome Asymptomatic Diseases Time Factors Heart Diseases / physiopathology complications diagnostic imaging Thromboembolism / etiology physiopathology Aged, 80 and over Atrial Function, Left

来  源:   DOI:10.1093/europace/euae120   PDF(Pubmed)

Abstract:
OBJECTIVE: Blood stasis is crucial in developing left atrial (LA) thrombi. LA appendage peak flow velocity (LAAFV) is a quantitative parameter for estimating thromboembolic risk. However, its impact on LA thrombus resolution and clinical outcomes remains unclear.
RESULTS: The LAT study was a multicentre observational study investigating patients with atrial fibrillation (AF) and silent LA thrombi detected by transoesophageal echocardiography (TEE). Among 17 436 TEE procedures for patients with AF, 297 patients (1.7%) had silent LA thrombi. Excluding patients without follow-up examinations, we enrolled 169 whose baseline LAAFV was available. Oral anticoagulation use increased from 85.7% at baseline to 97.0% at the final follow-up (P < 0.001). During 1 year, LA thrombus resolution was confirmed in 130 (76.9%) patients within 76 (34-138) days. Conversely, 26 had residual LA thrombi, 8 had thromboembolisms, and 5 required surgical removal. These patients with failed thrombus resolution had lower baseline LAAFV than those with successful resolution (18.0 [15.8-22.0] vs. 22.2 [17.0-35.0], P = 0.003). Despite limited predictive power (area under the curve, 0.659; P = 0.001), LAAFV ≤ 20.0 cm/s (best cut-off) significantly predicted failed LA thrombus resolution, even after adjusting for potential confounders (odds ratio, 2.72; 95% confidence interval, 1.22-6.09; P = 0.015). The incidence of adverse outcomes including ischaemic stroke/systemic embolism, major bleeding, or all-cause death was significantly higher in patients with reduced LAAFV than in those with preserved LAAFV (28.4% vs. 11.6%, log-rank P = 0.005).
CONCLUSIONS: Failed LA thrombus resolution was not rare in patients with AF and silent LA thrombi. Reduced LAAFV was associated with failed LA thrombus resolution and adverse clinical outcomes.
摘要:
目的:血瘀在左心房(LA)血栓形成中至关重要。左心耳峰值流速(LAAFV)是用于估计血栓栓塞风险的定量参数。然而,其对LA血栓消退和临床结局的影响尚不清楚.
结果:LAT研究是一项多中心观察性研究,调查经食管超声心动图(TEE)检测到的房颤(AF)和无症状LA血栓患者。在17,436例房颤患者的TEE手术中,297例患者(1.7%)患有无症状LA血栓。不包括没有随访检查的患者,我们纳入了169名基线LAAFV可用的患者.口服抗凝药物的使用从基线时的85.7%增加到最终随访时的97.0%(p<0.001)。在1年内,在76天(34-138天)内,在130例(76.9%)患者中确认了LA血栓消退。相反,26有残余的LA血栓,8人有血栓栓塞,5需要手术切除。这些血栓消退失败的患者的基线LAAFV低于成功消退的患者(18.0[15.8-22.0]vs.22.2[17.0-35.0],p=0.003)。尽管预测能力有限(曲线下面积,0.659;p=0.001),LAAFV≤20.0cm/s(最佳截止值)显著预测LA血栓消退失败,即使在调整了潜在的混杂因素(赔率比,2.72;95%置信区间,1.22-6.09;p=0.015)。不良结局的发生率,包括缺血性卒中/全身性栓塞,大出血,LAAFV降低的患者或全因死亡显着高于LAAFV保留的患者(28.4%vs.11.6%,对数秩p=0.005)。
结论:失败的LA血栓在房颤和无症状LA血栓患者中并不罕见。LAAFV降低与LA血栓消退失败和不良临床结局相关。
公众号